计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| U129821-5mg |
5mg |
现货 ![]() |
| |
| U129821-25mg |
25mg |
现货 ![]() |
| |
| U129821-100mg |
100mg |
现货 ![]() |
| |
| U129821-250mg |
250mg |
现货 ![]() |
|
| 英文别名 | 3n4b | HMS3872E13 | Q27467365 | Benzenesulfonamide, 4-((((4-fluorophenyl)amino)carbonyl)amino)- | HMS3651H21 | EX-A904 | 4-(((4-Fluoroanilino)carbonyl)amino)benzenesulfonamide | BDBM50075183 | AKOS001123930 | NCGC00379154-03 | SCHEMBL672955 | NSC 213841 | |
|---|---|
| 规格或纯度 | Moligand™, ≥98% |
| 英文名称 | U-104 |
| 生化机理 | 高效碳酸酐酶(CA)抑制剂(在MDA-MB-231细胞中,CA XII,CA IX,CA I和CA II的Ki值分别为4.5、45.1、5080和9640 nM)。抑制大鼠4T1转移模型中的肿瘤转移。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 碳酸酐酶 1 抑制剂;碳酸酐酶 12 抑制剂;碳酸酐酶 9 抑制剂 |
| 产品介绍 |
U-104是碳酸酐酶(Carbonic anhydrase)CA IX和CA XII高效抑制剂,Ki值分别为45.1nM和4.5nM。 U-104 is a potent carbonic anhydrase (CA) inhibitor for CA IX and CA XII with Ki of 45.1 nM and 4.5 nM; low inhibition for CA I and CA II. |
| 纯度 | ≥98% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 1-(4-fluorophenyl)-3-(4-sulfamoylphenyl)urea |
| INCHI | 1S/C13H12FN3O3S/c14-9-1-3-10(4-2-9)16-13(18)17-11-5-7-12(8-6-11)21(15,19)20/h1-8H,(H2,15,19,20)(H2,16,17,18) |
| InChi Key | YJQZNWPYLCNRLP-UHFFFAOYSA-N |
| Smiles | C1=CC(=CC=C1NC(=O)NC2=CC=C(C=C2)S(=O)(=O)N)F |
| Isomeric SMILES | C1=CC(=CC=C1NC(=O)NC2=CC=C(C=C2)S(=O)(=O)N)F |
| PubChem CID | 310360 |
| 分子量 | 309.32 |
| 溶解性 | 溶于DMSO, 最高浓度 (mg/mL): 30.93, 最高浓度(mM): 100 |
|---|---|
| 分子量 | 309.320 g/mol |
| XLogP3 | 1.500 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 5 |
| 可旋转键计数Rotatable Bond Count | 3 |
| 精确质量Exact Mass | 309.058 Da |
| 单同位素质量Monoisotopic Mass | 309.058 Da |
| 拓扑极表面积Topological Polar Surface Area | 110.000 Ų |
| 重原子数Heavy Atom Count | 21 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 450.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS07 |
|---|---|
| 信号词 | 警告 |
| 危险声明 |
H319: 引起严重眼睛刺激 |
| 预防措施声明 |
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P337+P317: 如果眼睛刺激持续:寻求医疗帮助。 |
| WGK Germany | 3 |
¥319.92
| 1. Pacchiano F, Aggarwal M, Avvaru BS, Robbins AH, Scozzafava A, McKenna R, Supuran CT. (2010) Selective hydrophobic pocket binding observed within the carbonic anhydrase II active site accommodate different 4-substituted-ureido-benzenesulfonamides and correlate to inhibitor potency.. Chem Commun (Camb.), 46 (44): (8371-3). [PMID:20922253] |
| 2. Pacchiano F, Carta F, McDonald PC, Lou Y, Vullo D, Scozzafava A, Dedhar S, Supuran CT. (2011) Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis.. J Med Chem, 54 (6): (1896-902). [PMID:21361354] |
| 3. Carta F, Vullo D, Osman SM, AlOthman Z, Supuran CT. (2017) Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs.. Bioorg Med Chem, 25 (9): (2569-2576). [PMID:28347633] |